https://www.selleckchem.com/pr....oducts/namodenoson-c
1, 0.028, 0.008, respectively). The present study provides further evidence that may be not a susceptibility gene for SZ. However, the genetic variations of may affect psychopathology symptoms. The present study provides further evidence that SLC1A1 may be not a susceptibility gene for SZ. However, the genetic variations of SLC1A1 may affect psychopathology symptoms. Neurostructural alterations are often reported in first episode of psychosis (FEP), but there is heterogeneity in the direction and location of findings between